Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells

Wook Kim, Maire E. Doyle, Zhuo Liu, Qizong Lao, Yu Kyong Shin, Olga D. Carlson, Hee Seung Kim, Sam Thomas, Joshua K. Napora, Eun Kyung Lee, Ruin Moaddel, Yan Wang, Stuart Maudsley, Bronwen Martin, Rohit N. Kulkarni, Josephine M. Egan

Research output: Contribution to journalArticle

Abstract

OBJECTIVE - Optimal glucose homeostasis requires exquisitely precise adaptation of the number of insulin-secreting β-cells in the islets of Langerhans. Insulin itself positively regulates β-cell proliferation in an autocrine manner through the insulin receptor (IR) signaling pathway. It is now coming to light that cannabinoid 1 receptor (CB1R) agonism/antagonism influences insulin action in insulin-sensitive tissues. However, the cells on which the CB1Rs are expressed and their function in islets have not been firmly established. We undertook the current study to investigate if intraislet endogenous cannabinoids (ECs) regulate β-cell proliferation and if they influence insulin action. RESEARCH DESIGN AND METHODS - We measured EC production in isolated human and mouse islets and β-cell line in response to glucose and KCl. We evaluated human and mouse islets, several β-cell lines, and CB1R-null (CB1R-/-) mice for the presence of a fully functioning EC system. We investigated if ECs influence β-cell physiology through regulating insulin action and demonstrated the therapeutic potential of manipulation of the EC system in diabetic (db/db) mice. RESULTS - ECs are generated within β-cells, which also express CB1Rs that are fully functioning when activated by ligands. Genetic and pharmacologic blockade of CB1R results in enhanced IR signaling through the insulin receptor substrate 2-AKT pathway in β-cells and leads to increased β-cell proliferation and mass. CB1R antagonism in db/db mice results in reduced blood glucose and increased β-cell proliferation and mass, coupled with enhanced IR signaling in β-cells. Furthermore, CB1R activation impedes insulin-stimulated IR autophosphorylation on β-cells in a Gαi-dependent manner. CONCLUSIONS - These findings provide direct evidence for a functional interaction between CB1R and IR signaling involved in the regulation of β-cell proliferation and will serve as a basis for developing new therapeutic interventions to enhance β-cell function and proliferation in diabetes.

Original languageEnglish (US)
Pages (from-to)1198-1209
Number of pages12
JournalDiabetes
Volume60
Issue number4
DOIs
StatePublished - Apr 2011

Fingerprint

Cannabinoid Receptors
Cannabinoids
Insulin Receptor
Cell Proliferation
Insulin
Islets of Langerhans
Insulin Receptor Substrate Proteins
Glucose
Cell Line
Cell Physiological Phenomena
Insulin-Secreting Cells
Blood Glucose
Homeostasis
Research Design
Ligands
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Kim, W., Doyle, M. E., Liu, Z., Lao, Q., Shin, Y. K., Carlson, O. D., ... Egan, J. M. (2011). Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells. Diabetes, 60(4), 1198-1209. https://doi.org/10.2337/db10-1550

Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells. / Kim, Wook; Doyle, Maire E.; Liu, Zhuo; Lao, Qizong; Shin, Yu Kyong; Carlson, Olga D.; Kim, Hee Seung; Thomas, Sam; Napora, Joshua K.; Lee, Eun Kyung; Moaddel, Ruin; Wang, Yan; Maudsley, Stuart; Martin, Bronwen; Kulkarni, Rohit N.; Egan, Josephine M.

In: Diabetes, Vol. 60, No. 4, 04.2011, p. 1198-1209.

Research output: Contribution to journalArticle

Kim, W, Doyle, ME, Liu, Z, Lao, Q, Shin, YK, Carlson, OD, Kim, HS, Thomas, S, Napora, JK, Lee, EK, Moaddel, R, Wang, Y, Maudsley, S, Martin, B, Kulkarni, RN & Egan, JM 2011, 'Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells', Diabetes, vol. 60, no. 4, pp. 1198-1209. https://doi.org/10.2337/db10-1550
Kim, Wook ; Doyle, Maire E. ; Liu, Zhuo ; Lao, Qizong ; Shin, Yu Kyong ; Carlson, Olga D. ; Kim, Hee Seung ; Thomas, Sam ; Napora, Joshua K. ; Lee, Eun Kyung ; Moaddel, Ruin ; Wang, Yan ; Maudsley, Stuart ; Martin, Bronwen ; Kulkarni, Rohit N. ; Egan, Josephine M. / Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells. In: Diabetes. 2011 ; Vol. 60, No. 4. pp. 1198-1209.
@article{fd1d417305784af4b477015b5eb1219b,
title = "Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells",
abstract = "OBJECTIVE - Optimal glucose homeostasis requires exquisitely precise adaptation of the number of insulin-secreting β-cells in the islets of Langerhans. Insulin itself positively regulates β-cell proliferation in an autocrine manner through the insulin receptor (IR) signaling pathway. It is now coming to light that cannabinoid 1 receptor (CB1R) agonism/antagonism influences insulin action in insulin-sensitive tissues. However, the cells on which the CB1Rs are expressed and their function in islets have not been firmly established. We undertook the current study to investigate if intraislet endogenous cannabinoids (ECs) regulate β-cell proliferation and if they influence insulin action. RESEARCH DESIGN AND METHODS - We measured EC production in isolated human and mouse islets and β-cell line in response to glucose and KCl. We evaluated human and mouse islets, several β-cell lines, and CB1R-null (CB1R-/-) mice for the presence of a fully functioning EC system. We investigated if ECs influence β-cell physiology through regulating insulin action and demonstrated the therapeutic potential of manipulation of the EC system in diabetic (db/db) mice. RESULTS - ECs are generated within β-cells, which also express CB1Rs that are fully functioning when activated by ligands. Genetic and pharmacologic blockade of CB1R results in enhanced IR signaling through the insulin receptor substrate 2-AKT pathway in β-cells and leads to increased β-cell proliferation and mass. CB1R antagonism in db/db mice results in reduced blood glucose and increased β-cell proliferation and mass, coupled with enhanced IR signaling in β-cells. Furthermore, CB1R activation impedes insulin-stimulated IR autophosphorylation on β-cells in a Gαi-dependent manner. CONCLUSIONS - These findings provide direct evidence for a functional interaction between CB1R and IR signaling involved in the regulation of β-cell proliferation and will serve as a basis for developing new therapeutic interventions to enhance β-cell function and proliferation in diabetes.",
author = "Wook Kim and Doyle, {Maire E.} and Zhuo Liu and Qizong Lao and Shin, {Yu Kyong} and Carlson, {Olga D.} and Kim, {Hee Seung} and Sam Thomas and Napora, {Joshua K.} and Lee, {Eun Kyung} and Ruin Moaddel and Yan Wang and Stuart Maudsley and Bronwen Martin and Kulkarni, {Rohit N.} and Egan, {Josephine M.}",
year = "2011",
month = "4",
doi = "10.2337/db10-1550",
language = "English (US)",
volume = "60",
pages = "1198--1209",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "4",

}

TY - JOUR

T1 - Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells

AU - Kim, Wook

AU - Doyle, Maire E.

AU - Liu, Zhuo

AU - Lao, Qizong

AU - Shin, Yu Kyong

AU - Carlson, Olga D.

AU - Kim, Hee Seung

AU - Thomas, Sam

AU - Napora, Joshua K.

AU - Lee, Eun Kyung

AU - Moaddel, Ruin

AU - Wang, Yan

AU - Maudsley, Stuart

AU - Martin, Bronwen

AU - Kulkarni, Rohit N.

AU - Egan, Josephine M.

PY - 2011/4

Y1 - 2011/4

N2 - OBJECTIVE - Optimal glucose homeostasis requires exquisitely precise adaptation of the number of insulin-secreting β-cells in the islets of Langerhans. Insulin itself positively regulates β-cell proliferation in an autocrine manner through the insulin receptor (IR) signaling pathway. It is now coming to light that cannabinoid 1 receptor (CB1R) agonism/antagonism influences insulin action in insulin-sensitive tissues. However, the cells on which the CB1Rs are expressed and their function in islets have not been firmly established. We undertook the current study to investigate if intraislet endogenous cannabinoids (ECs) regulate β-cell proliferation and if they influence insulin action. RESEARCH DESIGN AND METHODS - We measured EC production in isolated human and mouse islets and β-cell line in response to glucose and KCl. We evaluated human and mouse islets, several β-cell lines, and CB1R-null (CB1R-/-) mice for the presence of a fully functioning EC system. We investigated if ECs influence β-cell physiology through regulating insulin action and demonstrated the therapeutic potential of manipulation of the EC system in diabetic (db/db) mice. RESULTS - ECs are generated within β-cells, which also express CB1Rs that are fully functioning when activated by ligands. Genetic and pharmacologic blockade of CB1R results in enhanced IR signaling through the insulin receptor substrate 2-AKT pathway in β-cells and leads to increased β-cell proliferation and mass. CB1R antagonism in db/db mice results in reduced blood glucose and increased β-cell proliferation and mass, coupled with enhanced IR signaling in β-cells. Furthermore, CB1R activation impedes insulin-stimulated IR autophosphorylation on β-cells in a Gαi-dependent manner. CONCLUSIONS - These findings provide direct evidence for a functional interaction between CB1R and IR signaling involved in the regulation of β-cell proliferation and will serve as a basis for developing new therapeutic interventions to enhance β-cell function and proliferation in diabetes.

AB - OBJECTIVE - Optimal glucose homeostasis requires exquisitely precise adaptation of the number of insulin-secreting β-cells in the islets of Langerhans. Insulin itself positively regulates β-cell proliferation in an autocrine manner through the insulin receptor (IR) signaling pathway. It is now coming to light that cannabinoid 1 receptor (CB1R) agonism/antagonism influences insulin action in insulin-sensitive tissues. However, the cells on which the CB1Rs are expressed and their function in islets have not been firmly established. We undertook the current study to investigate if intraislet endogenous cannabinoids (ECs) regulate β-cell proliferation and if they influence insulin action. RESEARCH DESIGN AND METHODS - We measured EC production in isolated human and mouse islets and β-cell line in response to glucose and KCl. We evaluated human and mouse islets, several β-cell lines, and CB1R-null (CB1R-/-) mice for the presence of a fully functioning EC system. We investigated if ECs influence β-cell physiology through regulating insulin action and demonstrated the therapeutic potential of manipulation of the EC system in diabetic (db/db) mice. RESULTS - ECs are generated within β-cells, which also express CB1Rs that are fully functioning when activated by ligands. Genetic and pharmacologic blockade of CB1R results in enhanced IR signaling through the insulin receptor substrate 2-AKT pathway in β-cells and leads to increased β-cell proliferation and mass. CB1R antagonism in db/db mice results in reduced blood glucose and increased β-cell proliferation and mass, coupled with enhanced IR signaling in β-cells. Furthermore, CB1R activation impedes insulin-stimulated IR autophosphorylation on β-cells in a Gαi-dependent manner. CONCLUSIONS - These findings provide direct evidence for a functional interaction between CB1R and IR signaling involved in the regulation of β-cell proliferation and will serve as a basis for developing new therapeutic interventions to enhance β-cell function and proliferation in diabetes.

UR - http://www.scopus.com/inward/record.url?scp=79953216705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953216705&partnerID=8YFLogxK

U2 - 10.2337/db10-1550

DO - 10.2337/db10-1550

M3 - Article

C2 - 21346174

AN - SCOPUS:79953216705

VL - 60

SP - 1198

EP - 1209

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 4

ER -